Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC Effects on Glucose Metabolism in Type 2 Diabetes
NCT05322213Phase 1Recruiting
- Sponsor
- University of California, San Diego
- Start
- Aug 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of California, San Diego. Primary endpoints: Glucose Disposal Rate at 6 weeks and Vascular Endothelial Function at 6 weeks. Started Aug 2024; status: recruiting.
02
Drugs
dronabinol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05322213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05322213.